
May 15, 2026
UNC Study Reveals Promising New Therapy for Non-Hodgkin Lymphoma
The new study, led by researchers in the lab of Blossom Damania, PhD, has identified a new therapeutic target for difficult-to-treat cases of non-Hodgkin lymphoma

May 15, 2026
The new study, led by researchers in the lab of Blossom Damania, PhD, has identified a new therapeutic target for difficult-to-treat cases of non-Hodgkin lymphoma

May 14, 2026
The newly developed cells address a significant limitation present in existing treatment approaches and may offer a promising solution for acute myeloid leukemia.

April 24, 2026
The investment will help researchers develop innovative research projects aimed at improving the treatment of solid tumors, cervical cancer, lung cancer, and more.

February 19, 2026
New UNC study finds that a chemical derived from ashwagandha disrupts viral and cancer processes that make B-cell lymphomas difficult to treat with standard chemotherapy.

January 27, 2026
Microbiologists at the UNC School of Medicine point to a specific protein that interferes with common antibiotics and their abilities to completely kill off bacteria.

December 17, 2025
The newly revamped Center, located in the Thurston Bowles Building, is buzzing with undergraduates and high school students looking to get a head start on their scientific careers.

October 28, 2025
Researchers found that inhibiting a problematic protein in the body helps immunotherapies and CAR T-cell therapy to better fight off melanoma.

October 21, 2025
The Pediatric Infectious Diseases Society (PIDS) has named Dr. Matthew Vogt, Assistant Professor of Pediatrics (Infectious Diseases) and Microbiology & Immunology at the University of North Carolina at Chapel Hill, the recipient of its prestigious 2025 Young Investigator Award.

October 14, 2025
Microbiologists at the UNC School of Medicine identify a molecule that helps boost antibiotic effectiveness against staph, tuberculosis, and salmonella.

September 23, 2025
Experts at the UNC School of Medicine played a pivotal role in the approval of a new medication for pediatric patients that could also be used to treat other types of cancer.
September 19, 2025
Each year, the Postdoctoral Awards for Research Excellence (PARE) are given in recognition of the research promise demonstrated by individual postdoctoral scholars.

August 14, 2025
UNC School of Medicine third-year PhD student Celeste Robles and PhD advisor Helen Lazear named in 2025 cohort of the Howard Hughes Medical Institute (HHMI) Gilliam Fellows Program.